Deciphera Pharmaceuticals | 8-K: Current report
Deciphera Pharmaceuticals | DEFA14A: Others
Deciphera Pharmaceuticals | DEF 14A: Definitive information statements
Deciphera Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Deciphera Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Deciphera Pharmaceuticals | 8-K: Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2023 Financial Results
Deciphera Pharmaceuticals | 8-K: Current report
Deciphera Pharmaceuticals | 8-K: Deciphera Pharmaceuticals Announces Third Quarter 2023 Financial Results
Deciphera Pharmaceuticals | 8-K: Deciphera Pharmaceuticals Announces Second Quarter 2023 Financial Results
Deciphera Pharmaceuticals | 8-K: Current report
Deciphera Pharmaceuticals | 8-K: Current report
Deciphera Pharmaceuticals | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Deciphera Pharmaceuticals | 8-K: Deciphera Pharmaceuticals Announces First Quarter 2023 Financial Results
Deciphera Pharmaceuticals | DEFA14A: Others
Deciphera Pharmaceuticals | DEF 14A: Definitive proxy statements
Deciphera Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Deciphera Pharmaceuticals | 8-K: Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results
Deciphera Pharmaceuticals | 8-K: Current report
Deciphera Pharmaceuticals | 8-K: Current report
Deciphera Pharmaceuticals | 8-K: Current report
No Data